Biogen Inc.: Health Canada Grants Authorization for "LEQEMBI" (lecanemab) for the Treatment of Early Alzheimer's Disease

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
The Manila Times

Health Canada Grants Authorization for "LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or mild dementia due to Alzheimer’s disease (early AD) who are apolipoprote ...
Science-Based MedicineOpinion

The opposite of “turbo cancer”: COVID-19 vaccines sensitize cancer to immunotherapy

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
Washingtonian

This Maryland Mom Survived a Postpartum Stroke. She’s Been “Unstoppable” Ever Since.

Shortly after giving birth to her daughter, Erin Adelekun suffered a debilitating stroke. Determined to recover, she’s making remarkable progress—and giving hope to others.